Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safetyDEACON, Carolyn F; HOLST, Jens J.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 15, pp 2047-2058, issn 1465-6566, 12 p.Article

GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretionDEACON, Carolyn F; PLAMBOECK, Astrid; MØLLER, Søren et al.American journal of physiology. Endocrinology and metabolism. 2002, Vol 45, Num 4, pp E873-E879, issn 0193-1849Article

The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in miceROLIN, Bidda; DEACON, Carolyn F; CARR, Richard D et al.European journal of pharmacology. 2004, Vol 494, Num 2-3, pp 283-288, issn 0014-2999, 6 p.Article

What do we know about the secretion and degradation of incretin hormones?DEACON, Carolyn F.Regulatory peptides. 2005, Vol 128, Num 2, pp 117-124, issn 0167-0115, 8 p.Conference Paper

Effects of Sitagliptin and Metformin Treatment on Incretin Hormone and Insulin Secretory Responses to Oral and Isoglycemic Intravenous GlucoseVARDARLI, Irfan; ARNDT, Elisabeth; DEACON, Carolyn F et al.Diabetes (New York, NY). 2014, Vol 63, Num 2, pp 663-674, issn 0012-1797, 12 p.Article

Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetesTREMBLAY, André J; LAMARCHE, Benoît; DEACON, Carolyn F et al.Metabolism, clinical and experimental. 2014, Vol 63, Num 9, pp 1141-1148, issn 0026-0495, 8 p.Article

Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humansSNYDER, Eric M; CARR, Richard D; DEACON, Carolyn F et al.Applied physiology, nutrition and metabolism. 2008, Vol 33, Num 5, pp 929-935, issn 1715-5312, 7 p.Article

Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigsDEACON, Carolyn F; DANIELSEN, Patricia; KLARSKOV, Letty et al.Diabetes (New York, NY). 2001, Vol 50, Num 7, pp 1588-1597, issn 0012-1797Article

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patientsVILSBØLL, Tina; KRARUP, Thure; DEACON, Carolyn F et al.Diabetes (New York, NY). 2001, Vol 50, Num 3, pp 609-613, issn 0012-1797Article

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptideDEACON, Carolyn F; NAUCK, Michael A; MEIER, Juris et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 10, pp 3575-3581, issn 0021-972XArticle

Incretin Hormone and Insulin Responses to Oral Versus Intravenous Lipid Administration in HumansLINDGREN, Ola; CARR, Richard D; DEACON, Carolyn F et al.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 8, pp 2519-2524, issn 0021-972X, 6 p.Article

Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 DiabetesVARDARLI, Irfan; NAUCK, Michael A; KÖTHE, Lars D et al.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 4, pp 945-954, issn 0021-972X, 10 p.Article

Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?RAALTE, Daniel H. Van; KWA, Kelly A. A; GENUGTEN, Renate E. Van et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 4, pp 568-577, issn 0026-0495, 10 p.Article

Hyperglycemia Acutely Lowers the Postprandial Excursions of Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide in HumansVOLLMER, Kirsten; GARDIWAL, Husai; MENGE, Bjoern A et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 4, pp 1379-1385, issn 0021-972X, 7 p.Article

The Dipeptidyl Peptidase-4 Inhibitor Vildagliptin Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Fasting GlucoseUTZSCHNEIDER, Kristina M; TONG, Jenny; DEACON, Carolyn F et al.Diabetes care. 2008, Vol 31, Num 1, pp 108-113, issn 0149-5992, 6 p.Article

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patientsBALAS, Bogdan; BAIG, Muhammad R; CUSI, Kenneth et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 4, pp 1249-1255, issn 0021-972X, 7 p.Article

The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjectsVILSBØLL, Tina; AGERSØ, Henrik; LAURITSEN, Torsten et al.Regulatory peptides. 2006, Vol 137, Num 3, pp 168-172, issn 0167-0115, 5 p.Article

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?WEWER ALBRECHTSEN, Nicolai J; HARTMANN, Bolette; MADSBAD, Sten et al.Diabetologia (Berlin). 2014, Vol 57, Num 9, pp 1919-1926, issn 0012-186X, 8 p.Article

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humansBAK, Monika J; ALBRECHTSEN, Nicolai Wewer; PEDERSEN, Jens et al.European journal of endocrinology. 2014, Vol 170, Num 4, pp 529-538, issn 0804-4643, 10 p.Article

Preserved Inhibitory Potency of GLP-1 on Glucagon Secretion in Type 2 Diabetes MellitusHARE, Kristine J; KNOP, Filip K; ASMAR, Meena et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 12, pp 4679-4687, issn 0021-972X, 9 p.Article

Pharmacokinetics and pharmacodynamics of vildagliptin in patients with type 2 diabetes mellitusHE, Yan-Ling; SERRA, Denise; YIBIN WANG et al.Clinical pharmacokinetics. 2007, Vol 46, Num 7, pp 577-588, issn 0312-5963, 12 p.Article

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intakeRYSKJAER, Jakob; DEACON, Carolyn F; CARR, Richard D et al.European journal of endocrinology. 2006, Vol 155, Num 3, pp 485-493, issn 0804-4643, 9 p.Article

Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IVGRAM, Dorte X; HANSEN, Anker J; DEACON, Carolyn F et al.European journal of pharmacology. 2005, Vol 509, Num 2-3, pp 211-217, issn 0014-2999, 7 p.Article

Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigsTREBBIEN, Ramona; KLARSKOV, Letty; OLESEN, Mette et al.American journal of physiology. Endocrinology and metabolism. 2004, Vol 50, Num 3, pp E431-E438, issn 0193-1849Article

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic miceROLIN, Bidda; LARSEN, Marianne O; GOTFREDSEN, Carsten F et al.American journal of physiology. Endocrinology and metabolism. 2002, Vol 46, Num 4, pp E745-E752, issn 0193-1849Article